Abivax SA American Depositary Shares
ABVX Real Time Price USDRecent trades of ABVX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ABVX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
ABVX Revenue by Segment or Geography
New patents grants
-
Patent Title: Aryl-n-aryl derivatives for treating a rna virus infection Mar. 11, 2025
-
Patent Title: In vitro or ex vivo methods for screening a quinoline derivative Jan. 21, 2025
-
Patent Title: Phenyl-n-quinoline derivatives for treating a rna virus infection Sep. 10, 2024
-
Patent Title: Quinoline derivatives for use in the treatment of inflammation diseases May. 28, 2024
-
Patent Title: Combinations including abx196 for the treatment of cancer Nov. 28, 2023
-
Patent Title: Aryl-n-aryl derivatives for treating a rna virus infection Aug. 29, 2023
-
Patent Title: Use of quinoline derivatives for the treatment of inflammatory diseases May. 16, 2023
-
Patent Title: Use of quinoline derivatives for the treatment of inflammatory diseases May. 16, 2023
-
Patent Title: Mirna-124 as a biomarker Sep. 13, 2022
-
Patent Title: Compounds useful for treating cancer Aug. 30, 2022
-
Patent Title: Combinations including abx196 for the treatment of cancer Mar. 22, 2022
-
Patent Title: Abx196 for use in the treatment of bladder cancer Mar. 08, 2022
-
Patent Title: Compounds and pharmaceutical compositions containing at least one of the compounds May. 25, 2021
-
Patent Title: Use of quinoline derivatives for the treatment of inflammatory diseases Apr. 20, 2021
-
Patent Title: Compound, and production method thereof, and methods of treatment using the compound Apr. 13, 2021
-
Patent Title: Method of preparation of alpha galactosyl ceramides compounds Dec. 22, 2020
-
Patent Title: Quinoline derivatives for use in the treatment or prevention of viral infection Oct. 20, 2020
-
Patent Title: Compounds useful for treating cancer Jul. 21, 2020
-
Patent Title: Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging Jun. 16, 2020
-
Patent Title: Compounds for use as therapeutic agents affecting p53 expression and/or activity Jan. 21, 2020
-
Patent Title: Quinoline derivatives for the treatment of inflammatory diseases Oct. 08, 2019
-
Patent Title: Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging Apr. 09, 2019
-
Patent Title: Compounds useful for treating aids Jul. 10, 2018
-
Patent Title: Compounds useful for treating cancer May. 15, 2018
-
Patent Title: Compounds useful for treating aids Mar. 06, 2018
-
Patent Title: Compounds for use as therapeutic agents affecting p53 expression and/or activity Feb. 13, 2018
-
Patent Title: Compounds useful for treating diseases caused by retroviruses Nov. 28, 2017
-
Patent Title: Compounds for treating cancer May. 02, 2017
-
Patent Title: Use of rbm39 as a biomaker Jan. 31, 2017
-
Patent Title: Vaccine composition for use against influenza Dec. 29, 2015
-
Patent Title: Compounds useful for treating aids Sep. 29, 2015
-
Patent Title: Compounds useful for treating cancer Aug. 18, 2015
-
Patent Title: Compounds useful for treating aids Jun. 23, 2015
-
Patent Title: Methods of enhancing adjuvaticity of vaccine compositions Dec. 23, 2014
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to ABVX
Recent picks made for ABVX stock on CNBC
ETFs with the largest estimated holdings in ABVX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $ABVX stock a Buy, Sell, or Hold?
- What is the price target for $ABVX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ABVX stock?
- Who owns the most shares of $ABVX stock?
- What funds own $ABVX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ABVX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.